Deakin University
Browse

NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress

conference contribution
posted on 2018-11-01, 00:00 authored by Mustafa Khasraw, Kerrie L McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, Elizabeth Barnes, Mark Rosenthal, Craig Gedye, Elizabeth Hovey, Benjamin M Ellingson, John Simes, Annette Tongela, Helen Wheeler, Eng-Siew Koh, Hui Gan, Michael Back, Zarnie Lwin
NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress

History

Language

English

Publication classification

E3 Extract of paper

Volume

14

Pagination

196-197

ISSN

1743-7555

eISSN

1743-7563

Title of proceedings

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Publisher

WILEY